| Name | (S)-Cdc7-IN-18 |
|---|
| Description | (S)-Cdc7-IN-18 is a potent inhibitor of CDC7. Overexpression of huCdc7 promotes overactivation of MCM2, an important marker of tumor cells, and thus promotes aberrant proliferation of tumor cells. (S)-Cdc7-IN-18 has the potential for the research of cancer diseases (extracted from patent WO2020239107A1, compound 1-1)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Gang Li, et al. Tetracyclines as Cdc7 inhibitors. Patent WO2020239107A1. |
| Molecular Formula | C19H21N5OS |
|---|---|
| Molecular Weight | 367.47 |